Related Experiment Videos
Choline+ is a low-affinity ligand for alpha 1-adrenoceptors
L Unelius1, B Cannon, J Nedergaard
1Wenner-Gren Institute, Arrhenius Laboratories F3, Stockholm University, Sweden.
Biochemical Pharmacology
|October 7, 1994
Summary
Choline+, a sodium substitute, acts as a low-affinity competitive ligand at alpha 1-adrenoceptors. This interaction can interfere with [3H]prazosin binding in various tissues.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- Alpha 1-adrenoceptors are crucial for various physiological processes.
- Choline+ is frequently used as a sodium substitute in physiological buffer solutions.
- Understanding ion effects on receptor binding is essential for accurate experimental design.
Purpose of the Study:
- To investigate the effect of choline+ on ligand binding to alpha 1-adrenoceptors.
- To determine if choline+ acts as a competitive ligand at alpha 1-adrenoceptor binding sites.
- To assess the specificity of choline+'s interaction with alpha 1-adrenoceptors.
Main Methods:
- Radioligand binding assays using [3H]prazosin and [3H]CGP-12177.
- Competition binding experiments with choline+, phentolamine, and norepinephrine.
- Membrane preparations from brown adipose tissue, liver, and brain.
Main Results:
- Replacement of 25% sodium with choline+ decreased [3H]prazosin apparent affinity by 3-fold.
- Choline+ exhibited a calculated affinity (Ki) of 31 mM for the [3H]prazosin binding site.
- Choline+ did not affect binding to beta 1/beta 2-adrenoceptors, indicating specificity.
Conclusions:
- Choline+ acts as a low-affinity competitive ligand at alpha 1-adrenoceptors.
- The competitive interaction of choline+ can interfere with experimental measurements of alpha 1-receptor binding.
- Caution is advised when using choline+ as a sodium substitute in studies involving alpha 1-adrenoceptors.